Market Size of Fiducial Markers Industry
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 4.00 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Fiducial Markers Market Analysis
The Fiducial Markers Market is expected to register a CAGR of 4% during the forecast period. This is attributing to the growing incidence of cancer, rising awareness on radiotherapy, increasing public and private funding in cancer research. As per Globocan, in 2018 the number of new cases of all type of cancers were approximately 18,078957 worldwide. The presence of a huge cancer population will be leading to the increasing demand for treatments thus promoting the growth of fiducial marker as these markers are used in radiotherapy procedure which is mandatory treatment procedures in most of the cancer patients. Moreover, growing awareness about radiotherapy techniques such as image-guided radiotherapy, stereotactic radiosurgery and intensity-modulated radiotherapy and rising adoption of radiotherapy for oncology treatment will increase the adoption of fiducial markers and thus propel the overall market. Furthermore, technological advancements associated with an advanced navigation system that will help in accurate placement of product and rising investments, funds by private and public organization in cancer research will trigger the revenue growth of fiducial markers and thus these are some more factors which will fuel the growth of the market in coming years. However, alternate treatment options and complication with the product implantation and usage may hamper the market to certain extent.
